Donation

 

Black Swan Research Initiative Team

Team Leaders



 
Brian G.M. Durie, MD

Chairman and Co-Founder

International Myeloma Foundation

North Hollywood, California
Prof. Jesús San Miguel, MD

Director of Clinical and Translational Medicine

University of Navarra

Pamplona, Spain
S. Vincent Rajkumar, MD

Professor of Medicine and Chair of the Mayo Clinic

Myeloma, , and Dysproteinemia Group

Rochester, Minnesota

Iceland

 

Sigurdur Kristinsson, MD

University of Iceland

Reykjavík, Iceland

Stephen Harding, PhD

Research and Development Director

The Binding Site

Birmingham, United Kingdom

Kelly Endean

Head of Medical Science Liaison - Gammopathy

The Binding Site

Birmingham, United Kingdom

Sæmundur Rögnvaldsson

Researcher

University of Iceland

Reykjavík, Iceland

Ásdís Rósa Þórðardóttir

Project Manager

University of Iceland

Reykjavík, Iceland

Spain

 

Prof. Jesús San Miguel, MD

Director of Clinical and Translational Medicine

University of Navarra

Pamplona, Spain

Bruno Paiva, MD, PhD

University of Navarra

Pamplona, Spain

María-Victoria Mateos, MD, PhD

University of Salamanca

Salamanca, Spain

Alberto Orfao, MD, PhD

Department of Medicine, Cancer Research Center

University of Salamanca

Salamanca, Spain

Germany

Hartmut Goldschmidt, MD

Professor of Medicine (Hematology and Oncology) and Head of the Program

University Hospital Heidelberg

Heidelberg, Germany

Jens Hillengass, MD*

University of Heidelberg

Heidelberg, Germany

*Now moved to Roswell Park Cancer Center, Buffalo, New York

Australia

Andrew Spencer, MD

Head of the Malignant Haematology & Stem Cell Transplantation Service

The Alfred Hospital

Professor

Monash University

Melbourne, Australia

France

Hervé Avet-Loiseau, MD

Head of the Laboratory for Genomics in Myeloma

University of Toulouse

Toulouse, France

Philippe Moreau, MD

University Hospital

Nantes, France

United States

Brian G.M. Durie, MD

Chairman and Co-Founder

International Myeloma Foundation

North Hollywood, California

Suzanne Lentzsch, MD, PhD

Associate Professor of Medicine and Director of the and Program

Columbia University and at New York Presbyterian Hospital

New York, New York

Saad Usmani, MD

Director of Clinical Research (Hematologic Malignancies), Director of Plasma Cell Disorders

Levine Cancer Institute, Carolinas Healthcare System

Charlotte, North Carolina

 

I2TEAMM for FDA Submission

Brian G.M. Durie, MD

Chairman and Co-Founder

International Myeloma Foundation

North Hollywood, California

Shaji Kumar, MD

Professor of Medicine, Hematology

Mayo Clinic

Rochester, Minnesota

Nikhil Munshi, MD

Professor of Medicine, Harvard Medical School

Director of Basic and Correlative Science, Jerome Lipper Center

Dana-Farber Cancer Institute

Boston, Massachusetts

S. Vincent Rajkumar, MD

Professor of Medicine and Chair of the Mayo Clinic

Myeloma, , and Dysproteinemia Group

Rochester, Minnesota

Prof. Jesús San Miguel, MD

Director of Clinical and Translational Medicine

University of Navarra

Pamplona, Spain

Qian Shi, PhD

Associate Professor of Biostatistics and Senior Associate Consultant

Division of Biomedical Statistics and Informatics, Department of Health Sciences Research

Mayo Clinic Rochester, Rochester, MN

Philip McCarthy, MD

Professor of Oncology and Internal Medicine

Director, Blood and Marrow Transplant Center

Roswell Park Cancer Institute

Buffalo, New York

Paul Wallace, PhD

Professor of Oncology

Director, Department of Flow & Image Cytometry

Roswell Park Cancer Institute

Buffalo, New York

Theresa (Terri) Hahn, PhD

Professor of Oncology

Cancer Prevention and Population Sciences CCSG Program

Roswell Park Cancer Institute

Buffalo, New York

Joseph (Joe) Tario Jr., PhD

Senior Flow Cytometry Specialist

Department of Flow & Image Cytometry

Roswell Park Cancer Institute

Buffalo, New York

Marcelo Pasquini, MD

Associate Professor of Medicine

Scientific Director Center for International Blood and Marrow Transplant Research

Medical College of Wisconsin

Milwaukee, Wisconsin

Edward Stadtmauer, MD

Roseman, Tarte, Harrow, and Shaffer Families' President's Distinguished Professor

Section Chief, Hematologic Malignancies

University of Pennsylvania School of Medicine

Philadelphia, Pennsylvania

Hartmut Goldschmidt, MD

Professor of Medicine (Hematology and Oncology) and Head of the Program

University Hospital Heidelberg

Heidelberg, Germany

Dirk Hose, MD

Head of the Research Laboratory, Department of Internal Medicine

University of Heidelberg

Heidelberg, Germany

Stefanie Huhn, PhD

Department Head of the Research Laboratory

University of Heidelberg

Heidelberg, Germany

Hervé Avet-Loiseau, MD

Head of the Laboratory for Genomics in Myeloma

University of Toulouse

Toulouse, France

Philippe Moreau, MD

University Hospital

Nantes, France

Michel Attal, MD

General Director

Institut Universitaire du Cancer de Toulouse-Oncopole

Toulouse, France

Andy Rawstron, PhD

Department of Hematology

St. James's University Hospital

Leeds, United Kingdom

Roger Owen, MD

Consultant

St. James's University Hospital

Leeds, United Kingdom

Mario Boccadoro, MD

Professor

University of Torino

Torino, Italy

Stefania Oliva, MD

Myeloma Unit, Division of Hematology

University of Torino

Torino, Italy

Prof. Pieter Sonneveld, MD

Head of the Department of Hematology

Erasmus MC Cancer Institute, Rotterdam

The Netherlands

Shaji Kumar, MD

Professor of Medicine, Hematology

Mayo Clinic

Rochester, Minnesota

Kenneth (Ken) Anderson, MD

Kraft Family Professor of Medicine, Harvard Medical School

Physician, Oncology, Brigham And Women's Hospital

Dana-Farber Cancer Institute

Boston, Massachusetts

 

CESAR Trial

María-Victoria Mateos, MD, PhD

Director of the Myeloma Unit

University Hospital of Salamanca

Salamanca, Spain

Prof. Alberto Orfao, MD, PhD

Department of Medicine, Cancer Research Center

University of Salamanca

Salamanca, Spain

Bruno Paiva, MD, PhD

University of Navarra

Pamplona, Spain

Prof. Jesús San Miguel, MD

Director of Clinical and Translational Medicine

University of Navarra

Pamplona, Spain

Joan Bladé, MD

Hospital Clínica de Barcelona

Barcelona, Spain

Juan José Lahuerta, MD

Hospital Universitario 12 de Octubre

Madrid, Spain

 

ASCENT Trial

Brian G.M. Durie, MD

Chairman and Co-Founder

International Myeloma Foundation

North Hollywood, California

Shaji Kumar, MD

Professor of Medicine, Hematology

Mayo Clinic

Rochester, Minnesota

Global Consortium

 

Wee-Joo Chng, MD, PhD Professor, Yong Loo Lin School of Medicine, National University of Singapore

Associate Director, Research, National University Cancer Institute, Singapore

Deputy Director, Cancer Science Institute of Singapore, National University of Singapore

Meletios Dimopoulos, MD

Professor and Chairman of the Department of Clinical Therapeutics

University Athens School of Medicine

Athens, Greece

Juan Du, MD

Changzhen Hospital

Shanghai, China

Roman Hajek, MD, PhD

Professor

University Hospital Brno and Masaryk University

Brno, Czech Republic

Heinz Ludwig, MD

Professor

Wilhelminenspital

Wien, Austria

Hareth Nahi, MD

Associate Professor

Karolinska University Hospital

Stockholm, Sweden

Evangelos Terpos, MD, PhD



University Athens School of Medicine

Athens, Greece

 

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.